UK Lucentis Biosimilar Nod Offers Teva Potential First-Mover Advantage

Formycon-Bioeq Partnered Ongavia Receives First European Approval In UK

 
• By David Wallace
  
UK red on map of Europe
The UK has given Teva and partner Formycon a first European ranibizumab approval • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products